This Ancient Sea Creature Builds Its Body With a Whisper, not a Scream – The New York Times

Building a body from scratch is a daunting task, one that requires careful coordination among all those involved. Thats why natures starting stuff cells have learned to be remarkably chatty to get the job done right.

Decades of experiments on embryos from fish, frogs and mice have painted a general picture of the way these cellular conversations often go. Cells will emit molecular signals that can diffuse deep into their environment, not unlike messages broadcast over radio waves. Such widely transmitted messages, which direct information to distant anatomical locales, have long been considered essential to the act of building a body.

It is what is discussed in textbooks, said Lo Guignard, a biologist at the Max Delbrck Center for Molecular Medicine in Berlin.

But nature has developed subtler ways of sending messages, too.

By eavesdropping on the embryos of sea squirts, saclike filter feeders that inhabit the worlds shallow ocean floors, Dr. Guignard and his colleagues may have identified another way that burgeoning cells correspond. During their earliest days, sea squirt cells seem to exchange signals only with their nearest neighbors, rather than dispatching signals to cells that are farther afield, according to a paper published Thursday in Science.

Its the microscopic equivalent of passing notes between close friends a talking tactic that may be more limited in reach than its long-range counterpart, but could allow for the delivery of especially precise instructions.

Most researchers in the field of developmental biology have never really thought about cell signaling in this way, said Chen Cao, who researches sea squirt development at Princeton University but wasnt involved in the new study. This is a brand-new angle on how embryo cells find their fates, she said.

Sea squirts are more closely related to vertebrates animals like humans with backbones than you might expect from brainless blobs. And the embryos of some sea squirt species, such as Phallusia mammillata, are completely transparent, making them especially easy to observe.

The researchers used a highly sensitive form of microscopy to track 10 Phallusia mammillata embryos during six hours of their early development. Snapping images every two minutes, the cameras recorded the position and shape of each cell in the embryo through multiple rounds of division, until the sea squirts-to-be each contained several hundred cells apiece, about a third of the way through development.

Unlike frog or mouse embryo cells which may zip to and fro during development, young sea squirt cells stayed mostly in place. Mathematical modeling also showed that the cells signaled only to the cells they touched, almost like they were whispering to one another. In at least these early stages of development, sea squirt cells didnt seem to need long-distance chatter.

The findings raise the possibility that you can be a whole, sophisticated embryo by way of local signals alone, said Patrick Lemaire, a developmental biologist at the University of Montpellier in France and a co-author of the study.

Remarkably, these patterns repeated themselves in all the sea squirts the team observed, to the point where the same cells occupied nearly identical neighborhoods in different embryos. Dr. Lemaire said he thinks this rigid consistency may have played some role in keeping the squishy forms of sea squirts mostly unchanged since they first appeared on the planet hundreds of millions of years ago.

This is a beautiful piece of work, said Cassandra Extavour, a developmental biologist at Harvard University who wasnt involved in the study. And though sea squirts are the only creatures in which these developmental patterns have been rigorously documented so far, Dr. Extavour said she expects there will be many, many more animals that rely on a signaling principle like the one outlined here.

Different types of signaling also arent mutually exclusive. Dr. Cao said she thinks even sea squirt cells might make some long-distance calls later in development.

Scientists have long looked for a unifying view of how cell-cell communication works across animals, said Didem Sarikaya, a developmental biologist at the University of California, Davis, who wasnt involved in the study. But its becoming increasingly clear that is not the case, Dr. Sarikaya said.

We tend to observe the things we have already known about before, Dr. Extavour said. But if we understand this lens is very narrow, we might not be surprised by findings like this.

Link:

This Ancient Sea Creature Builds Its Body With a Whisper, not a Scream - The New York Times

NantHealth Points To The Future Of Healthcare – Seeking Alpha

MantHealth (NH) offers cancer molecular profiling solutions that enable personalization in a number of cancer treatments. This business, which has been lingering for a couple of years has received an important FDA approval which makes approval for Medicare and Medicaid use very likely. This, together with the sale of their Connected Care business has boosted the stock price significantly, but we think it's not too late to step on board.

The company is also is enabling a more integrated and data-driven healthcare solution through its two SaaS platforms, which are growing and account for most of the company's revenues to date.

These proven integration solutions are offered to an industry, which as they claim (and, dare we say, not without reason) suffers from a host of unnecessary complexity and inefficiencies, most notably:

Because of these inhibitions, the healthcare system is struggling to make the shift towards a more holistic, data-driven approach, the culmination of which is individualized medicine.

Personalized medicine is based on personalized data that is increasingly becoming available through advances in molecular medicine and real-time biometrics (remote monitoring devices and the like).

These solutions, like the company's own GPS business, generate a veritable deluge of data which, for a coordinated and individualized approach need to be collected, analyzed and distributed, and it's here where the company's SaaS solutions intervene and add value. We'll quickly introduce the company's solutions below.

From the 10-K:

GPS Cancer is a comprehensive molecular profile that integrates whole genome/exome (DNA) sequencing of tumor and normal germline samples and whole transcriptome (RNA) sequencing, providing oncologists with insights into the unique molecular signature of a patients cancer to inform personalized treatment strategies.

What GPS Cancer does is comparing the patient's whole genome/exome sequencing of a persons tumor sample with their normal sample in order to highlight molecular alterations that are specific to their tumor DNA.

These alterations are then subsequently confirmed by RNA sequencing. All this enables the matching of these alterations with drugs that might be effective against tumors containing the specific change. And these solutions are constantly fine-tuned by machine learning.

This is the company's blood based test that allows non-invasive profiling of tumors and monitoring quantitative response to treatment, from the 10-K:

Liquid GPS looks beyond cfDNA to cfRNA, which allows profiling and trending of actionable biomarkers that cannot be assessed through cfDNA alone. In addition to providing molecular insight into key guidelines-based biomarkers (e.g., EGFR, ALK, ROS1, KRAS), this powerful RNA-based approach enables a variety of capabilities and applications not typically available from a liquid biopsy test.

It is able to monitor targeted therapies, immunotherapy and chemotherapy responses.

This is the company's SaaS based decision support system which provides evidence-based clinical decision support for physicians who are threatened to be overwhelmed by today's rapid advancements in molecular and biometric medicine.

Eviti centralizes stuff like clinical content, treatment cost from Medicare reimbursements and treatment toxicity data. It has access to over 7600 clinical trials and 4000+ evidence-based treatment regimes.

NaviNet Open is a payer-provider workflow collaboration platform in order to increase efficiency, lower cost, improve provider satisfaction and enable communication between health plans and providers.

The company sold its Connected Care business for $47M in February to Masimo (MASI), exiting DCX, VCX, HBox and Shuttle Cable. The Connected Care business generated $1.2M in sales in Q1, a small part of overall revenue ($23M).

While operational performance has improved, the company hasn't been able to grow much in the past four years:

Data by YCharts

After the sale of its Connected Care business, the company has two revenue categories:

To date, the company's SaaS revenue generates most of its revenue but it does gain some revenue from sequencing and molecular analysis. However, last quarter saw a big decline to just $59K (down from $814K a year ago).

The stagnant revenue in part is just appearance as the company's SaaS business has been growing, from $60.7M in 2017 to $65.6M in 2018 to $72.8M in 2019, because the company de-emphasized its GPS business as costs were outweighing revenues. The company keeps on adding new customers (like here and here) to its SaaS businesses, a few were mentioned on the Q1CC.

The company keeps improving their products and adding new Eviti and NaviNet features.

For this business to take off, the wait is basically for a positive coverage determination from CMS, from the Q1CC:

we expect to continue to see minimal sequencing and molecular analysis revenue impact until we receive a positive coverage determination from CMS.

However, that event seems near, from the 10-K (our emphasis):

In the fourth quarter of 2019, we received FDA 510(K) authorization for Omics Core, the nations first FDA authorized whole exome tumor-normal in vitro diagnostic (IVD) that measures overall tumor mutational burden (TMB) in cancer tissue, completing a key step towards achieving Medicare coverage.

Which, together with the sale of the Connected Care business, explains the rally in the shares, from FinViz:

It's GPS business generated $2.55M in revenues in 2017, $3.13M in 2018 and $1.73M in 2019. Here too, apart from the FDA approval for Omics Core, there are other developments and improvements.

The company launched a new AI platform which can automatically distinguish sub-types lung cancer pathology and improves on that ability, from PR:

Derived from deep-learning models, together, the findings demonstrate a novel AI-based method for subtyping lung cancer pathologies which impacts treatment options for patients and improved methods of identifying tumor infiltrating white cells found elevated in lung cancer.

Accurately identifying and quantifying tumor-infiltrating white cells is extremely important for prognosis and treatment decisions in this era of personalized medicine, yet it currently requires manual review of whole slide images by medically trained pathologists, and incurs significant delays and cost, explains Dr. Patrick Soon-Shiong, MD, Chairman and CEO of NantHealth.

And they are working on a similar solution for breast cancer. In principle, their TMB (tumor mutational burden) test capability is a generic capability with wide application scope, here is a description of the mechanics from company PR:

Omics Core reports a cancer patient's overall TMB by sequencing and comparing 19,396 protein-coding genes targeting 39 million base pairs of the human genome from a tumor sample and a normal sample, typically from blood or mucosal membrane. TMB indicates the sum of all acquired gene-coding mutations in a tumor genome and is increasingly used to predict response to therapy and identify tumors that could benefit from immunotherapy. In addition, the test reports somatic mutations in 468 cancer-relevant genes accurate to 2% allele frequency, to inform clinical decisions about patient treatment. "Tumor mutation burden ... is now recognized as a key biomarker across multiple tumor types," said Patrick Soon-Shiong, chairman and CEO of Nanthealth. "Studies have shown that immunotherapy treated with high TMB had better outcomes compared to those with low TMB."

And here is a description of a peer reviewed article how this improves targeting capabilities of treatments. It's the more general applicability of TMB and the FDA approval that shareholders are rejoicing.

According to management, two things stand out (PR, our emphasis):

Nanthealth is positioning its tumor-normal test as an advancement over competitors like Myriad Genetics Inc., Color Genomics Inc. and Invitae Corp., which have limited gene panels to look at hereditary risk. By sequencing the whole exome, "we have the ability to identify things that others are missing, and that's particularly critical for drug development," Sandeep Reddy, Nanthealth's chief medical officer, told BioWorld MedTech. "We know about maybe cancer risk, but what do we know about autism or Alzheimer's? By getting that information, that becomes transformative."

As described in that PR, the company's TMB test spots things that other solutions don't, resulting in a more personalized approach to what therapies might be more successful, and it has applicability beyond screening for cancers.

But from a financial point of view, things are also going pretty well.

Data by YCharts

GAAP margins have been trending up and gross margin was much better than a year ago (60% versus 49%), up on product mix (the shift towards its SaaS business).

Operating expenses declined from $20.2M in Q1 2019 to $16.8M in Q1 2020, but $1.1M of that decline is related to the sold Connected Care business.

While cash flow is still negative, there has been tremendous improvement in the last 2.5 years.

Data by YCharts

The net cash burn in Q1 was still around $5M, but this included various closing costs and other front-end loaded costs in relation to the sale of the Connected Care business.

And with that sale the balance sheet has improved a lot, with the company having $47.5M in cash on the books, although the company does have a substantial $95.3M in long-term debt, from the 10-Q:

Data by YCharts

The valuation has jumped along with the share price recently but we think it's still not excessive, it has been much higher in the past on a much more distant promise of monetizing their TMB solutions and in the meantime the company developed a successful SaaS business with their Eviti and NaviNet platforms.

With a backwards looking EV/S of 8X for a company with a unique product that is about to get monetized and a successful SaaS business is high, but not overly so. Analyst still expect EPS losses, $0.23 this year falling to -$0.18 next year, but the company doesn't burn much cash and has plenty of it.

While much is uncertain about the potential of the company's GPS business and the economics of it, the company does have unique capabilities that are likely to become important tools in fighting a number of cancers and the underlying capabilities seem to have wide applicability.

Add to that an attractive SaaS business a declining cash burn and the sale of its Connected Care business providing enough cash to keep the company going for the foreseeable future, and we think we still have an attractive proposition for shareholders, even if it looks like the shares might want to have to digest recent strong gains.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Continued here:

NantHealth Points To The Future Of Healthcare - Seeking Alpha

University of Bristol research investigates the effects of climate change on pollinators and human health – Epigram

By Jade Bruce, Second year, Cellular and Molecular Medicine

Climate change has a global impact. University of Bristol scientists are leading an international team to investigate how climate change may lead to the decline of pollinators and the effect this may have on human.

Spring and summer are the months where blossoming trees line parks, flowers of every colour erupt into full bloom and bees whizz from plant to plant. Although despite being the most well-known bees are not the only pollinators which deserve our recognition. From beetles to bats, an array of pollinators provides a free yet vital service of transporting pollen between plants necessary for fertilization.

Researchers at the University of Bristol have received 1 million from The Belmont Forum to lead and collaborate alongside an international team, investigating the effects of climate change on pollinators, and in turn on human diet and health.

Unpredictable weather patterns, shifting timing of seasons and extreme temperatures associated with climate change, put pollinators under threat. The concerning decline in their populations is currently being observed all around the world. A study carried out by The WWF and Buglife, in the east of England, found that 17 species of bee have already gone regionally extinct.

Indeed, around 90% of the worlds wild plants and of crop species depend primarily on animal-mediated pollination. Pollinators around the globe are key to ensuring that there is nutritious food on our supermarket shelves and in our fridges. This essential service has been placed in jeopardy due to the far-reaching impacts of climate change.

Pollination enables the production of seeds and is an essential process for the reproduction of many different plants. Transfer of pollen can occur through several means, such as by wind and water. However, the most common and efficient pollination method is animal-mediated. Animals pollinate a wide range of plants, including those which produce fruit, vegetables, nuts, and spices.

The decline of pollinators does not only have a destructive effect on biodiversity, but also a major impact on global food production. The term ecological Armageddon has been aptly coined to describe the loss of our pollinators. Pollinator decline is closely correlated to more frequent declines in the crop yields they pollinate.

This is predicted to have negative impacts on human health, as the essential micronutrients which we get from these foods, such as folate and Vitamin A, are thus lacking from our diet. Food insecurity, as well as decreased access to healthy food and subsequently increased food prices, are therefore possible outcomes of pollinator losses due to climate change.

Access to affordable food remains a challenge for the 736 million people worldwide living in extreme poverty. Pollinator decline threatens to exacerbate the existing barriers to sufficient and nutritious diets. The Bristol research team is focussing their investigations on Nepal, where many already suffer from severe micronutrient deficiencies.

Developing countries, have a greater reliance on the micronutrients found in pollinator-dependent crops, and less access to foods or supplements that could replace these lost. Hence, as seen across many global issues, the impact of pollinator loss is not felt equally certain countries will be disproportionately harmed.

Loss of pollinators could also result in rising rates of micronutrient malnutrition and maybe unexpectedly obesity. This is likely due to the fact that people are forced to turn to cheap, high energy, but less nutritious staple foods. The decline of insect pollinators is representative of the wider decline of biodiversity due to human behaviour.

The worlds climate is our natural life-support system, which provides us with dependable ecosystem services. Climate change and public health are not mutually exclusive: a climate crisis is a public health crisis.

What can one do to tackle this crisis? Jane Memmott, Professor of Ecology at the University of Bristol School of Biological Sciences, said: Climate change is a critical global issue that is already affecting pollinators but, at a local level, pollinator declines can be reversed. Additionally, if the effect of climate change on pollinators is understood, habitat management can be used to mitigate against its effects.

More locally, we can restore the damaged habitats of pollinators and attract them back into gardens and cities by planting pollen-rich flowers, providing water and creating nest sites for wild pollinators.

Some food for thought: maybe next time you see a bee buzzing by, dont swat it away in fear instead, thank it for doing such an almighty job.

Featured: Frank Lammel / UN Women / Asif A. Ali | flickr

Are you pleased by the University of Bristols efforts into exploring the effects of climate change on pollinators and human health?

Read the original:

University of Bristol research investigates the effects of climate change on pollinators and human health - Epigram

Peer-reviewed JNU study among 2 that link BCG & Covid again, but some experts not convinced – ThePrint

Text Size:A- A+

Bengaluru: Two studies released this week, one led by Indian researchers from JNU, brought back a theory that first emerged in the early days of the pandemic that BCG vaccination may be linked to reduced Covid-19 transmission and mortality.

One of them, published in the journal Cell Death and Disease on 8 July, was carried out by an international team of researchers. It was led by researchers from the JNU School of Computer and System Sciences, in collaboration with colleagues from the universitys Special Centre for Molecular Medicine and School of Computational and Integrative Sciences, besides those from Italy, China and the US.

The second study, published in PNAS on 9 July, was carried out by American researchers.

The first study involved an assessment of a possible correlation between Covid-19 incidence and mortality with the BCG vaccine, which is primarily targeted at tuberculosis. It also sought to examine the preventive use of chloroquine, an antimalarial drug that has been touted as a potential coronavirus prophylactic and treatment.

While it found a potential correlation between a nations BCG policy and lowered disease incidence/mortality, it failed to find a statistically significant correlation with chloroquine.

The American study also found a potential correlation between BCG vaccination rates and Covid mortality, but the authors suggested further research into the subject.

Both journals are peer-reviewed, but PNAS allows authors to pick reviewers. The studies were both observational assessments based on existing data and not based on clinical trials. The authors themselves acknowledge certain limitations and experts have called for more research before a conclusive link can be proved.

We are deeply grateful to our readers & viewers for their time, trust and subscriptions.

Quality journalism is expensive and needs readers to pay for it. Your support will define our work and ThePrints future.

SUBSCRIBE NOW

Also Read: Can BCG vaccine protect against Covid-19? Heres why the excitement needs to be tempered

The BCG vaccine has been in use since 1921, but works only for an average of 60 per cent of the population. Its use has reduced drastically after decades of vaccination drives the world over, including in the Indian subcontinent.

Today, it is proving inefficient against lung TB, the most common form of the disease in India, but there are studies underway to find a replacement.

But there is some evidence that BCG offers protection to some unrelated viruses like influenza.

The Cell authors classified countries into three groups on the basis of their BCG policy: Countries that never adopted universal BCG vaccination, ones that did but subsequently discontinued it, and ones that currently exercise it.

The authors reportedly found that the number of cases across different age groups was always higher for countries without a BCG policy. For adults aged over 45, vaccinated groups had significantly lower case rates. Vaccination rates did not seem to matter in children under 15 since disease incidence in this group was found to be low.

The PNAS study, too, noted that countries with no vaccination policy had a higher rate of deaths than those that did. Both studies claim that the case load was marginally lower even in countries with interrupted or irregular BCG drives.

The Cell team further speculates that the type of BCG vaccine strain used also plays a role, citing high prevalence despite vaccination in Brazil and Russia.

Many countries, including Germany, the Netherlands, Australia, and the US, have initiated trials of BCG vaccines aimed at controlling Covid-19. Immunologist Gobardhan Das, who participated in the Cell study, claims to be working on developing a revamped BCG vaccine for Covid-19.

Also Read: We need to take a break from real-time updates on the Covid vaccine trials. BCG is a far cry

Many observational studies have suggested a link between BCG and Covid-19, but experts in immunology and BCG have called for more research.

It is true that India has had several decades of safe experience with BCG, which has a proven safety record, is inexpensive, and easily available, said Dr S.P. Kalantri, an epidemiologist and medical superintendent at Kasturba Hospital in Wardha, Maharashtra. But using only observational ecological studies to find a pattern with BCG is problematic.

Ecological studies are observational assessments where existing data is analysed, retrospectively, based on geography, and conclusions drawn from them usually form the basis for further studies.

Intuitively, it seems natural that there is a cause and effect relationship, but what holds true for a country does not hold true for communities or individuals, Kalantri said. In epidemiology, he added, this is called an ecological fallacy.

Kalantri said there are other factors that could contribute to Covid-19 data being the way it is, the most important of which is the average age of the population. The average age of most BCG countries, he added, is lower than that of non-BCG nations.

We know that incidence and mortality is age-specific. As age advances, prevalence and mortality also goes up. In the face of such factors, we shouldnt fall into the trap of concluding that the disease pattern is because of BCGs effects, he added. We need proper randomised controlled trials to show statistical significance, he said.

Said Madhukar Pai, epidemiologist at McGill University, Canada, Several countries now have rapidly escalating Covid-19 outbreaks, including Brazil, India, Russia, Mexico, Peru, Chile. And they all routinely give BCG at birth. So, it is dangerous to make conclusions in such a dynamic situation. We simply cannot act on these ecologic correlations and must wait for randomised trials on BCG and Covid-19.

The study authors also noted their own limitations.

The Cell study only included data from middle- and high-income countries.

The PNAS study stated that the data is difficult to review because of broad differences between countries in socioeconomic status, demographic structure, rural vs urban settings, time of arrival of the pandemic, number of tests and criteria, etc.

Also Read: Why the fight over a coronavirus vaccine will be intense, irrational and even nasty

Subscribe to our channels on YouTube & Telegram

News media is in a crisis & only you can fix it

You are reading this because you value good, intelligent and objective journalism. We thank you for your time and your trust.

You also know that the news media is facing an unprecedented crisis. It is likely that you are also hearing of the brutal layoffs and pay-cuts hitting the industry. There are many reasons why the medias economics is broken. But a big one is that good people are not yet paying enough for good journalism.

We have a newsroom filled with talented young reporters. We also have the countrys most robust editing and fact-checking team, finest news photographers and video professionals. We are building Indias most ambitious and energetic news platform. And we arent even three yet.

At ThePrint, we invest in quality journalists. We pay them fairly and on time even in this difficult period. As you may have noticed, we do not flinch from spending whatever it takes to make sure our reporters reach where the story is. Our stellar coronavirus coverage is a good example. You can check some of it here.

This comes with a sizable cost. For us to continue bringing quality journalism, we need readers like you to pay for it. Because the advertising market is broken too.

If you think we deserve your support, do join us in this endeavour to strengthen fair, free, courageous, and questioning journalism, please click on the link below. Your support will define our journalism, and ThePrints future. It will take just a few seconds of your time.

Support Our Journalism

Original post:

Peer-reviewed JNU study among 2 that link BCG & Covid again, but some experts not convinced - ThePrint

Blood Type And Coronavirus Risk: What You Need To Know – Medical Daily

Recent studies claimed that blood types can either help block COVID-19 or increase the risk of getting the disease and its complications. The findings provided hope to many people but health experts warned it may be too early to put our guards down.

Majority of those studies found that people with Type O blood are less likely to catch the novel coronavirus, while those with Type A are more vulnerable. Experts fear that the findings would give people a false sense of security and encourage them to stop following common safety measures, such as wearing masks and social distancing.

In one study in Europe, researchers found that Type A blood increases risk of severe COVID-19 cases by 45 percent. They said people with this blood type are more likely to require oxygen support or a ventilator because of the disease.

Meanwhile, the Type O blood group appeared with 35 percent lower risk. The study analyzed the blood and conditions of 1,610 patients with severe COVID-19 and 2,205 healthy participants.

Other studies in China and New York also provided the same findings in favor of people with Type O blood. However, the possible influence of blood type on COVID-19 appears small compared with other risk factors, such as age and underlying health condition, according to Aaron Glatt, chair of medicine and chief of infectious diseases at Mount Sinai South Nassau in New York.

People with Type O blood "certainly shouldn't walk around high-fiving and saying, I can do whatever I want, I don't have to mask, I don't have to worry about anything because I have O," Glatt, who is also a spokesperson for the Infectious Diseases Society of America, said. "And they shouldn't crawl into a corner of the world and not let anyone near them because they have A. Everybody should practice exactly the same way, whatever your blood type is, in terms of appropriate masking and social distancing."

The studies also did not suggest that Type O people are completely safe from the serious complications of COVID-19. Researchers said they can still get very sick because of the coronavirus infection.

"They have a decreased risk to get infected and to develop severe disease," Andre Franke, author of the European study and professor of molecular medicine at the University of Kiel in Germany, told NBC News. "However, this is only a relative risk reduction, i.e. there is no full protection. Among our patients who died there were also many with blood group O."

A researcher collects blood samples in an unknown laboratory. Pixabay

Continue reading here:

Blood Type And Coronavirus Risk: What You Need To Know - Medical Daily

Top 25 healthtech influencers to follow on Twitter – Sifted

Healthtech is a hefty sector, spanning digital health, femtech, pharma, AI-assisted diagnostics, drug discovery and plenty more.

It makes money too, and a lot of it. In 2019, global healthtech investment totalled a staggering $7.4bn, with some of Europes healthtech companies landing big funding rounds. Last years biggest European healthtech deal came from London-based unicorn Babylon Health which raised $550m, while this year Stockholm-based digital health startup Kry raised $155m and Paris-based health insurance provider Alan raised $54m.

Theres also a fair few influencers in the healthtech Twittersphere founders, investors and medical professionals who are a goldmine of information opening discussions, sharing resources and educating their followers.

Check out the European healthtech accounts not to miss.

Get the Sifted Newsletter

Thank you for subscribing to the newsletter!

Handle: @joannashields

Who? Shes the chief executive of BenevolentAI, which uses AI to enhance and accelerate scientific discovery, drug discovery and development processes.

Why should you care? The unicorn has shaken the healthtech sector since it was founded in 2013, with the mission to find treatments for the thousands of untreated diseases on our planet. Shields is known for her long and successful career in the tech industry with a focus on using technology to improve humanity, and is leading one of the most ambitious projects to combat diseases including Covid-19.

How about those tweets? If youre looking for updates on finding treatments for Covid-19, insights into AI healthtech and notes on diversity data in healthtech, Shields Twitter feed is the one to keep your eye on.

Handle: @petetrainor

Who? The chief executive of Vala Health, a digital doctor video consultation company.

Why should you care? The digital consultation industry has boomed over the past few months due to Covid-19, and Trainor is in the middle of it all. On top of that, his work as an author takes a uniquely philosophical approach to technology, and he has made a name for himself speaking across the globe on topics such as data and AI. Hes also active in raising awareness about mens mental health and suicide.

How about those tweets? Trainor can be seen opening discussions via Twitter polls on topics such as Covid-19 tracing apps, and is not afraid to (sometimes sarcastically) speak his mind. Definitely an account to follow for those who love to sink their teeth into a debate.

Handle: @MarijaButkovic

Who? Shes the chief executive of Women of Wearables (WoW), an organisation that supports, connects and inspires women who work primarily in wearable tech.

Why should you care? Butkovic is a living library, often writing and blogging on a range of topics from wearable tech, startups and diversity, and is all for helping support female communities in tech. One key ambition at WoW is to show that womens health is not niche by changing perceptions, ending bias and raising awareness.

How about those tweets? Butkovics Twitter feed checks all the boxes for a femtech fanatic. Shes very active in circulating posts and blogs from other women in tech, often about innovations in femtech, and uses her platform to shine light on conversations from webinars and panels she has been on.

Handle: @berci

Who? The director of the Medical Futurist Institute, a research institute with a mission to open discussions about digital health and the future of healthcare.

Why should you care? Mesko is a physician and sci-fi fanatic with a PhD in genomics, and is a prominent keynote speaker known for his engaging and insightful talks on all things digital health. He also stays on top of disruptive trends in medicine, and works with organisations, governments, pharmaceutical and tech companies to take advantage of those.

How about those tweets? Everything under the sun about digital health features on Meskos Twitter feed, from smartphone healthtech tips to portable ultrasound scans and the effect of telemedicine and Covid-19. Look out for his sci-fi book recommendations, or literature relating to healthtech and medicine.

Handle: @ManeeshJuneja

Who? Juneja is a digital health futurist and consultant.

Why should you care? He sees data, and using it correctly, as the key to improving the health of populations through means such as technology. Juneja has unfortunately been battling coronavirus for three months, and has become focused on how we should be using technology to combat the virus. He encourages his followers to think about how health and technology will be affected by the global pandemic.

How about those tweets? Juneja is extremely active on the platform, posting Twitter thread deep dives on his experiences and thoughts while having the virus. These threads cover everything from his symptoms to self isolation tips, and thoughts on how governments and health organisations can handle the outbreak in effective ways.

Handle: @_atanas_

Who? Atanasov is a scientist in molecular medicine and digital health, as well as the editor-in-chief for CRBIOTECH, a biotech journal.

Why should you care? An expert in medicine and a recognised biotech influencer, Atanasov strives to better understand the mechanisms that regulate health and disease and has carried out leading research in areas such as drug discovery.

How about those tweets? Atanasov is a pro at helping his followers understand the complexities of medicine, biotech and digital health, and often calls out new digital health innovations, such as the AI applications that can help healthcare. Also, if you want to learn the latest ins and outs behind very specific topics around Covid-19, like whether youre sick for life after getting the disease, Atanasov has been hot on such posts recently.

Handle: @sophiabendz

Who? Shes a partner at the VC firm Atomico, but will be moving to Cherry Ventures in September this year.

Why should you care? Most people have probably heard Bendz name in the European venture capital and angel investing space. Shes been actively investing in femtech companies for years, including period tracking app Clue and sexual wellness app Ferly.

How about those tweets? Bendz tweets in English and Swedish, and often shares posts on femtech from an investor point of view. Expect to see a lot more on early-stage startups, perhaps in the femtech space, when Bendz joins Cherry Ventures.

Handle: @IlonaKickbusch

Who? She is the director of Kickbusch Health Consult, a global health advisory for organisations, governments and NGOs.

Why should you care? Kickbusch has proven to be quite a big voice in health policy recently, contributing to the agenda for the Health 2020 European policy framework. Shes also concerned about how these policies can leverage healthtech possibilities in the future.

How about those tweets? If you want to look at European health policy through the lens of healthtech, Kickbusch is your go-to. She often posts about the importance of data in health, while starting conversations with her audience, for example, can an AI face mask tracker be effective during the pandemic?

Handle: @health20Paris

Who? Shes the CEO of Basil Strategies, a communications consultancy dedicated to digital health.

Why should you care? Denise is a Paris-based thought leader, with over 20 years experience in digital health. Her company helps clients such as startups, pharmaceutical organisations and hospitals to push forward digital projects. Shes also passionate about the application of virtual reality (VR) in the context of health.

How about those tweets? Youll often find Silber promoting the use of VR as a provider of therapy, recommending insightful articles and podcasts on digital health, so VR lovers should check it out. She tweets in French and English.

Handle: @LionelREICHARDT

Who? He is a consultant for healthtech organisations and a popular healthtech blogger, also known as Pharmageek.

Why should you care? Reichardt has over 15 years of experience in the pharmaceutical industry. While completing his MBA in e-business, he adopted the persona of Pharmageek, gained a large following and has become a respected and influential online speaker on topics such as digital health.

How about those tweets? Whats the next wave of healthcare innovation? Whos leading the latest digital health solutions? What are employers looking for in the healthtech sector right now? Reichardts Twitter feed, primarily in French, covers it all.

Link:

Top 25 healthtech influencers to follow on Twitter - Sifted

Fine-tuning brain activity reverses memory problems in mice with autism mutation – Spectrum

Social circuitry: Mice with an autism-linked mutation have better social memory after treatment that calms a related neural circuit.

Georgejason / iStock

Dampening overactive brain circuits alleviates social and spatial memory problems in a mouse model of 22q11.2 deletion syndrome, according to a new study1. The findings hint at the possibility of novel treatments for some difficulties associated with the syndrome.

Deletions of DNA in a chromosomal region known as 22q11.2 often cause intellectual disability or other cognitive difficulties, as well as psychiatric conditions such as schizophrenia. About 16 percent of people with the deletion also have autism2.

The type and severity of traits vary from person to person, in part because the deletion can span roughly 20 to 50 genes. That range makes it difficult to design targeted therapies. And many people with deletions in 22q11.2 are prone to drug-related side effects, such as seizures.

Side effects with drug treatment is one of the hardest parts of dealing with mental illness, says Julia Kahn, a postdoctoral researcher at the Childrens Hospital of Philadelphia in Pennsylvania, who worked on the study. Being able to circumvent that in a very directed manner would be really life-changing for a lot of people.

The study identifies the neural circuits responsible for select behaviors in model mice and shows that manipulating those circuits could offer a new treatment strategy.

It suggests that therapies can be symptom specific, says lead investigator Douglas Coulter, professor of pediatrics and neuroscience at the University of Pennsylvania in Philadelphia.

Coulter and his colleagues manipulated circuits in two regions of the hippocampus in 22q11.2 model mice: the ventral region, which governs social memory, and the dorsal region, involved in spatial memory. They focused on the hippocampus because it is important to social cognition in both mice and people, and previous studies have shown it is unusually small in people with 22q11.2 deletions3.

Before the manipulation, mice missing 22q11.2 perform worse than controls on tests of their social and spatial memory, the study shows. The mice do not distinguish between a new mouse and one they have already met, and they have trouble recognizing when an object in their cage has been moved. Brain imaging also showed that the model mice have overactive neurons in the hippocampus.

The team used a method known as chemogenetics to dampen this overactivity. They gave the mice an injection that prompts some neurons in the hippocampus to produce designer receptors. They then injected the animals with an experimental drug that binds only to those receptors, making the neurons less excitable.

The animals behaviors changed, depending on where they received the injection. Social memory improved when the drug targeted the ventral hippocampus, and spatial memory improved when the drug affected neurons in the dorsal area. Too much inhibition in either area caused the animals memory problems to return.

Using the same technique, the researchers also gave control mice drug-sensitive receptors that either activate or quell the same circuits in the hippocampus. After both treatments, the controls showed the same social memory problems as the mice with 22q11.2 deletions. The results indicate that disrupting the circuits in either direction is enough to change behavior, even without any underlying genetic mutations. The findings were published in May in Biological Psychiatry.

Chemogenetics is a long way off from use in people, but drugs currently on the market may be able to achieve similar outcomes by nudging circuits into a more balanced state, says Peter Scambler, professor of molecular medicine at University College London in England, who was not involved in the work.

Its a proof of principle, he says.

Manipulating circuits that govern specific behaviors should be a goal of all current work at this point, says Anthony LaMantia, professor of developmental disorders and genetics at Virginia Polytechnic Institute and State University in Blacksburg, who was not involved in the work. This is much more targeted and precise. It should make everybody in the field think through how to design their experiments.

Targeting circuits in the hippocampus could help people, because findings in the hippocampus in mice typically translate well to humans, says Rebecca Piskorowski, head of the synaptic plasticity and neuronal circuits team at the Institute of Psychiatry and Neuroscience of Paris in France, who was not involved in the work.

This kind of targeting might also help at any age. The method improved memory in adult mice, suggesting similar treatments could help older people with 22q11.2 deletions and not just children.

This paper shows if you just adjust the activity in a tiny little place, you can somehow compensate for all those developmental problems, Piskorowski says. That is particularly exciting.

Originally posted here:

Fine-tuning brain activity reverses memory problems in mice with autism mutation - Spectrum

Now, local masks that claim to kill the covid-19 virus – Livemint

If you happen to encounter the covid-19 virus, it could survive for hours, even days, on your mask and possibly spread inside your home. The very thing that is supposed to protect me can become a harmful carrier," says Anandkumar, co-founder of Bugworks, a startup developing new antibiotics. Hes also a mentor to a diverse set of scientists and entrepreneurs who have come together under the aegis of Bengaluru-based startup I Shield to create antiviral products, starting with a covid-killer mask.

Co-founder and director of I Shield Ashok Vohra is former chairman of Singapore-based life sciences company Esco. Co-founder and director Jogin Desai, former CEO of multinational clinical research company Cenduit, is also the founder of cell therapy startup Eyestem. Another co-founder Nitish Sathyanarayanan runs a startup, Aiyon Life in Bengaluru, which is developing therapies from venom peptides. Two scientific advisors are Ram Subramanian, former director and co-founder of the Centre for Cellular and Molecular Platforms (C-CAMP) in Bengaluru, and Robert Deschenes, who chairs the department of molecular medicine at the University of South Florida.

Lab certificates

The I Shield mask has six layers. The outermost and innermost layers have a patent-pending tekFABRIK infused with an IS 212 molecule. Lab tests have shown this mask kills the SARS-CoV-2 virus responsible for the covid-19 pandemic.

The Rajiv Gandhi Centre for Biotechnology in Thiruvananthapuram, a nodal organization to study the novel coronavirus, put us through exacting tests. We got a 99.99% kill rate on SARS-CoV-2 repeatedly," says Anandkumar. Tests at C-CAMP and University of South Florida showed the mask kills other flu viruses and disease-causing bacteria, apart from the covid-19 virus.

The way the masks IS 212 molecule works is similar to how soap and alcohol destroy the covid-19 virus. Within minutes it ruptures the lipid envelope of the virus, which makes it unstable. Once you rupture the virus envelope, the RNA or genetic material gets exposed, making the virus inactive," explains Sathyanarayanan.

This is unlike a drug which targets the virus itself to stop it from attaching to a host or slow its replication. The virus needs a lipid envelope to survive. Rupturing that is one strategy to prevent its spread.

The I Shield team went through hundreds of molecules to see which were best at rupturing the virus envelope. The next requirement was to bind it to a fabric in an affordable and scalable way, which made IS 212 the best candidate. Another molecule had better activity, but it involved many more steps for synthesis which made it costly," says Sathyanarayanan.

The next step was clearance from the South India Textile Research Association (SITRA), a government-accredited body for testing and certification of products as safe for people to use. Although SITRA has cleared the mask for public use, further certification will be required for it to be deemed medical grade for use in hospitals.

Weve started a parallel process to get it classified and certified as a medical device," says Vohra. For now, I Shield is going to market for everyday use of its mask.

The masks are manufactured by subcontractors in Bengaluru. One of I Shields founding directors is Hitesh Topiwala, owner of Paramount Cosmetics, who is looking at manufacturing and distribution.

I Shield is exploring various channels to scale up availability. We are in talks with one of the largest mask manufacturers in India to see if they will buy our tekFABRIK and use their own brand on the masklike the concept of Intel Inside," says Vohra.

The mask is currently priced at 199 a piece. Other options are on the anvil, such as a crowdfunding campaign. The team has been talking with the government and Niti Aayog to see if public sector production facilities can be roped in to make a version available for around 50, possibly with tweaks in the current six-layered design.

The masks are just a starting point. Other uses of the IS 212 molecule are in the pipeline. For example, it could be used on cab or airplane seats. We have engineered linkers that can bind it to plastic, glass, metal and wood. They can stay bound to surfaces for three or four days, unlike ethanol-based disinfectants which evaporate in minutes," says Sathyanarayanan.

While the main mode of transmission of the covid-19 virus appears to be saliva or mucus droplets, touching infected surfaces is a significant contributor. So we can imagine a scenario where all kinds of surfaces, including our backpacks, would need to be coated with a killer fabric.

Swiss rivals

Swiss company Livinguard has come out with antiviral masks that researchers at Free University of Berlin tested on coronavirus. The companys website says it was tested to neutralize HCoV-229E, a generally accepted surrogate for SARS-CoV-2". The way it works appears similar to I Shieldthe differences will be in price, availability, and certification for efficacy against SARS-CoV-2. HeiQ is another Swiss company licensing its antiviral technology to textile manufacturers.

The Indian governments interest in I Shield comes from its technology having been developed in India with certificates from accredited labs locally as well as abroad, says Anandkumar who has been involved with parleys with officials. A local supply chain opens avenues for mass production at affordable price points within the country.

When Anandkumar got together with Vohra a few years ago to create a biotech incubator, anti-pollution masks were one of their projects. That was the genesis of I Shield but it went on the backburner.

Then covid-19 arrived. We had a bunch of nerdy scientists, so we turned up the heat on the science behind masks," says Anandkumar. We used screening techniques, pulled out a commercial molecule and found a smart way to covalently bind it to a cotton substrate."

Cotton makes the mask comfortable to use in India. The binding keeps the covid-killer molecule attached to the fabric through multiple washes. In lab tests, its efficacy reduced by 2% in 30 washes and 5% in 70 washes," says Sathyanarayanan. Disposal of used masks is a hazard because they carry the virus. Thats another problem these masks solve.

Mass availability and certification for use by healthcare personnel are the next milestones to cross for an Indian product with potential to have a significant impact on the spread of covid-19.

Sumit Chakraberty is a Consulting Editor with Mint. Write to him at chakraberty@gmail.com

Subscribe to newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

More:

Now, local masks that claim to kill the covid-19 virus - Livemint

US death toll on the rise again as cases surge in the sunbelt states – Independent.ie

The coronavirus death toll in the US has started to climb again as the recent surge in cases in the sunbelt states feeds through into fatalities.

At least 867 people died of Covid-19 on Thursday in the US and the crucial seven-day average has begun to climb after falling steadily since mid-April, when deaths first peaked at more than 2,000 a day.

For several weeks President Donald Trump has been blaming the country's surging case numbers on the availability of more tests and has suggested that test capacity should be cut to reverse the trend.

However, intensive care wards have been filling up across the sunbelt states from Florida to California and now, as had been predicted by experts, deaths have started to climb again. The trend bodes ill not just for those caught up in the outbreak, the bulk of whom are from poor and Black, Asian and minority ethnic communities, but for the president himself - who is hoping to be elected for a second term in November.

In terms of recorded cases, the US has become the worst-affected country, with more than 3.1 million diagnosed Covid-19 cases and at least 133,291 deaths since the crisis started in January.

The US Centres for Disease Control (CDC) predicts the nation's coronavirus death toll will rise to between 140,000 to 160,000 deaths by August.

The trend is predicted to continue unless social distancing can be effectively reinstituted across the south and mid-west of the country.

"As predicted, a month from the case surge started, we are moving to a higher death rate in the US," tweeted Dr Eric Topol, a Professor of Molecular Medicine at the Scripps Research Institute in California.

"I think the shift to younger patients and better treatments will lead to a flatter slope compared with April. But thwarting the surge could have prevented this altogether."

The rise in deaths comes as the leading public health expert in the US, Dr Anthony Fauci, said he had not briefed the president for two months, and he last saw him in person on June 2. In an interview with the 'Financial Times', Dr Fauci said he was "sure" the information shared at his meetings with the vice-president's coronavirus task force was being passed to Mr Trump.

Discussing rising case numbers, he said: "What worries me is the slope of the curve. It still looks like it's exponential."

Meanwhile, France yesterday became the sixth country to report a total coronavirus death toll of more than 30,000, with the number of new confirmed cases above 600 for the third day in a row.

The health ministry said in a statement that 25 people had died from coronavirus infection in the past 24 hours, boosting the cumulative total since early March to 30,004.

Yesterday's increase compares with an average increase of 15 in the previous seven days. In June, France counted on average 34 new deaths per day, in May 143 and in April 695. The number of people in hospital with Covid-19 fell by 115 to 7,062, continuing a weeks-long downtrend, and the number of people in intensive care units fell by 16 to 496, the first time the ICU count had fallen below 500 since mid-March.

The number of confirmed coronavirus infections rose by 658 to 170,752, the third day in a row with more than 600 new infections, compared with an average of 495 over the past 30 days and 527 over the past seven days.

The Czech Republic reported 82 new cases of the novel coronavirus by late afternoon yesterday, bringing its total since the start of the pandemic above 13,000, after a recent uptick in infections caused by local outbreaks.

The country of 10.7 million has reported 352 deaths from Covid-19, far fewer than its Western European neighbours. It was one of the first European countries to impose drastic lockdown measures in March, but has lifted many restrictions since May.

Since June 18, it has reported at least 100 new cases a day 14 times, most recently on Thursday when the total was 105. The largest spike came on June 28, when 305 new cases were reported.

Irish Independent

See more here:

US death toll on the rise again as cases surge in the sunbelt states - Independent.ie

Powerful Medical Benefit: The Right Way to Breathe During the Coronavirus Pandemic – SciTechDaily

By Louis J. Ignarro, UCLAJuly 8, 2020

Inhale through your nose and exhale through your mouth. Its not just something you do in yoga class breathing this way actually provides a powerful medical benefit that can help the body fight viral infections.

The reason is that your nasal cavities produce the molecule nitric oxide, which chemists abbreviate NO, that increases blood flow through the lungs and boosts oxygen levels in the blood. Breathing in through the nose delivers NO directly into the lungs, where it helps fight coronavirus infection by blocking the replication of the coronavirus in the lungs. But many people who exercise or engage in yoga also receive the benefits of inhaling through the nose instead of the mouth. The higher oxygen saturation of the blood can make one feel more refreshed and provides greater endurance.

I am one of three pharmacologists who won the Nobel Prize in 1998 for discovering how nitric oxide is produced in the body and how it works.

Nitric oxide is a widespread signaling molecule that triggers many different physiological effects. It is also used clinically as a gas to selectively dilate the pulmonary arteries in newborns with pulmonary hypertension. Unlike most signaling molecules, NO is a gas in its natural state.

NO is produced continuously by the 1 trillion cells that form the inner lining, or endothelium, of the 100,000 miles of arteries and veins in our bodies, especially the lungs. Endothelium-derived NO acts to relax the smooth muscle of the arteries to prevent high blood pressure and to promote blood flow to all organs. Another vital role of NO is to prevent blood clots in normal arteries.

In addition to relaxing vascular smooth muscle, NO also relaxes smooth muscle in the airways trachea and bronchioles making it easier to breathe. Another type of NO-mediated smooth muscle relaxation occurs in the erectile tissue (corpus cavernosum), which results in penile erection. In fact, NO is the principal mediator of penile erection and sexual arousal. This discovery led to the development and marketing of sildenafil, trade name Viagra, which works by enhancing the action of NO.

Other types of cells in the body, including circulating white blood cells and tissue macrophages, produce nitric oxide for antimicrobial purposes. The NO in these cells reacts with other molecules, also produced by the same cells, to form antimicrobial agents to destroy invading microorganisms including bacteria, parasites and viruses. As you can see, NO is quite an amazing molecule.

Since NO is a gas, it can be administered with the aid of specialized devices as a therapy to patients by inhalation. Inhaled NO is used to treat infants born with persistent pulmonary hypertension, a condition in which constricted pulmonary arteries limit blood flow and oxygen harvesting.

Inhaled NO dilates the constricted pulmonary arteries and increases blood flow in the lungs. As a result, the red blood cell hemoglobin can extract more lifesaving oxygen and move it into the general circulation. Inhaled NO has literally turned blue babies pink and allowed them to be cured and to go home with mom and dad. Before the advent of inhaled NO, most of these babies died.

Inhaled NO is currently in clinical trials for the treatment of patients with COVID-19. Researchers are hoping that three principal actions of NO may help fight covid: dilating the pulmonary arteries and increasing blood flow through the lungs, dilating the airways and increasing oxygen delivery to the lungs and blood, and directly killing and inhibiting the growth and spread of the coronavirus in the lungs.

In an in vitro study done in 2004 during the last SARS outbreak, experimental compounds that release NO increased the survival rate of nucleus-containing mammalian cells infected with SARS-CoV. This suggested that NO had a direct antiviral effect. In this study, NO significantly inhibited the replication cycle of SARS-CoV by blocking production of viral proteins and its genetic material, RNA.

In a small clinical study in 2004, inhaled NO was effective against SARS-CoV in severely ill patients with pneumonia.

The SARS CoV, which caused the 2003/2004 outbreak, shares most of its genome with SARS CoV-2, the virus responsible for COVID-19. This suggests that inhaled NO therapy may be effective for treating patients with COVID-19. Indeed, several clinical trials of inhaled NO in patients with moderate to severe COVID-19, who require ventilators, are currently ongoing in several institutions. The hope is that inhaled NO will prove to be an effective therapy and lessen the need for ventilators and beds in the ICU.

The sinuses in the nasal cavity, but not the mouth, continuously produce NO. The NO produced in the nasal cavity is chemically identical to the NO that is used clinically by inhalation. So by inhaling through the nose, you are delivering NO directly into your lungs, where it increases both airflow and blood flow and keeps microorganisms and virus particles in check.

While anxiously awaiting the results of the clinical trials with inhaled NO, and the development of an effective vaccine against COVID-19, we should be on guard and practice breathing properly to maximize the inhalation of nitric oxide into our lungs. Remember to inhale through your nose; exhale through your mouth.

Written by Louis J. Ignarro, the Distinguished Professor Emeritus of Molecular & Medical Pharmacology, School of Medicine, University of California, Los Angeles.

Originally published on The Conversation.

Originally posted here:

Powerful Medical Benefit: The Right Way to Breathe During the Coronavirus Pandemic - SciTechDaily

rsted backs out of offshore wind connection at Fenwick Island – The News Journal

Fishermen say there isn't enough known about the impacts of offshore wind. With two projects in the work off Delmarva, fishermen are worried about their livelihoods. Salisbury Daily Times

OCEAN CITY, Md.The construction of an interconnection facility at Fenwick Island State Park is no longer in the works due to environment concerns, according to an announcement from rsted.

rsted and the Delaware Department Natural Resources and Environmental Control have worked together since July 2019 to create a connection point for the Skipjack Wind Farm.rsted offered to invest $18 million in the state parkin exchange for the opportunity to build an interconnection facility.

rsted has "pivoted" away from Fenwick Island because of the park's "undisturbed wetlands," according to the announcement.

This draft rendering shows where the interconnection facility will be, in the top of the photo to the left of the highway along the bay side of Fenwick Island State Park. On the ocean side are some renderings of improvements such as a new visitor center and pedestrian overpass.(Photo: Courtesy of DNREC)

"Constructing an interconnection facility on a site with such an extensive presence of undisturbed wetlands runs contrary torsted's deeply held commitment to building our business sustainably," said Brady Walker, Mid-Atlantic market manager forrsted.

More: Delmarva wind farms delayed to 2023-24, developers blame U.S. government for setback

More than 200 people attended a statemeeting in November 2019, many of whom were against the project, according to The New Journal. The agreement was made quietly, with discussions not held in public.

The company said it plans to announce a newlocation for the interconnection facility in the coming weeks.

The interconnection facility at Fenwick Island would have connected directly to the Skipjack Wind Farm, bringing energy captured by the wind turbines from 19 miles offshore to land.

This map shows where an offshore wind lease area is along Delaware's coast. The yellow portion is where the Skipjack Wind Farm will be placed.(Photo: Bureau of Ocean Energy Management)

The Skipjack Wind Farm is a 120 megawatt offshore wind farm under development off the coast of Delaware and Maryland.rsted says when the project is complete the wind farm will power 35,000 homes on the Delmarva Peninsula.

More: Was Delawares connection to offshore wind born in secrecy? Depends who you ask(for subscribers)

Background: Offshore wind company wants to build on state parkland, offering upgrades in exchange

rsted is one of the world's largest offshore wind developers and is currently building several projects off the East Coast of the U.S., including off of Virginia and Delaware.

rsted is currently building the Coastal Virginia Offshore Wind Farm, which will be operational by the end of 2020, according torsted. The 12-megawatt wind farm will be located 27 miles off the coast of Virginia Beach.

The project is part of a larger effort by Dominion Energy to build the largest wind farm in the U.S., according to Dominion Energy.

Read or Share this story: https://www.delmarvanow.com/story/news/local/delaware/2020/07/10/orsted-backs-out-offshore-wind-connection-fenwick-island-delaware-ocean-city-maryland-skipjack/5412515002/

Read the original:

rsted backs out of offshore wind connection at Fenwick Island - The News Journal

Interior Department to streamline offshore wind permitting, nix unsolicited leasing – Utility Dive

Dive Brief:

States along the East Coast have issued ambitious goals for offshore wind, and industry stakeholders, including prospective developers, have urged BOEM for more federal leasing opportunities.

BOEM identified "deregulatory opportunities" on offshore wind developments, that will add more flexibility to geophysical and geothechnical survey submission requirements, streamlining approval of meteorological buoys, revising project verification procedures, and providing "greater clarity regarding safety requirements." The Trump administration is pushing deregulation and streamlined permitting as a general approach for energy and other projects.

"This latest process announcement from BOEMoffers some long-term hope for improvement, but the time is now; the federal government cant wait or delay using its existing tools to spur economic investment,"Noah Shaw, partner at Hodgson Russ and former general counsel at the New York State Energy Research and Development Authority (NYSERDA), told Utility Dive.

"Of course, the proof will be in the pudding as this process moves along, as to whether BOEM can deliver on the promise of improvement," he said.

The practice of unsolicited lease requests has served to inform BOEM of interest in offshore leasing, but the continued interest in leasing activity has become well-established. While stakeholders await the notices of proposed rulemakings, state energy officials are also keen on more federal leasing areas.

"We've been extremely clear with the federal government for a number of years about the need for new lease areas that could serve New York, and now the broader region ... as other goals have also shifted,"Doreen Harris, Acting President and CEO of NYSERDA, told Utility Dive.

NYSERDA is progressing with its second offshore wind solicitation notwithstanding any earlier implications from the COVID-19 pandemic earlier in 2020. The agency is working"to maintain the market momentum" established in the state's first solicitation for a total 1.7 GW of offshore wind in 2019, she said."We need to continue our work and we need BOEM to continue their leasing and permitting."

New York does not need additional federal leasing for its upcoming 2.5 GW offshore wind solicitation, according to Harris, but federal action is needed to assure the industry's future growth.

BOEM will host two webinars on Tuesday and Thursday on its new Supplemental Environmental Impact Statement forthe 800 MW Massachusetts offshore wind project, Vineyard Wind.

"The fact that BOEM has made the progress that they did [on Vineyard Wind] is encouraging on its surface," Harris said of the 420-page filing.

Read the original here:

Interior Department to streamline offshore wind permitting, nix unsolicited leasing - Utility Dive

Hermitage Offshore Services Ltd. Announces Forbearance Agreement with the Lenders to its $132.9 Million Term Loan Facility – Hellenic Shipping News…

Hermitage Offshore Services Ltd. announced that it has executed a forbearance agreement (the Forbearance Agreement) to its $132.9 Million Term Loan Facility dated January 14, 2020 (the Term Loan Facility) with DNB Bank ASA and Skandinaviska Enskilda Banken AB (publ) (together, the Lenders) and DNB Bank ASA, as agent and security agent. While the Forbearance Agreement does not address the long-term liquidity and restructuring needs of the Company, pursuant to the terms of the Forbearance Agreement, the Lenders have agreed to forbear from exercising any of their rights and remedies under the Term Loan Facility and any other finance agreements related to the Term Loan Facility in the event of a default by the Company until July 31, 2020.

As previously announced, the outbreak of the novel coronavirus coupled with the collapse in the price of crude oil has resulted in a significant and abrupt deterioration in the financial condition of the Company. These events have given rise to substantial doubt about the Companys ability to continue as a going concern. As a result, the Company has engaged Perella Weinberg Partners and Snapdragon Advisory AB as financial advisors and Proskauer Rose LLP as legal counsel to analyze restructuring alternatives and has been in ongoing discussions with the Lenders in an effort to address these issues.Source: Hermitage Offshore Services Ltd.

Read more from the original source:

Hermitage Offshore Services Ltd. Announces Forbearance Agreement with the Lenders to its $132.9 Million Term Loan Facility - Hellenic Shipping News...

Newfoundland and Labrador’s offshore oil and gas industry represents one of the lowest carbon per barrel footprints in the world. | OUR GREAT MINDS -…

Community and business leaders, as well as supporters throughout Canada, are united to send a clear message to the Government of Canada that action is needed to attract investment in the offshore oil and gas industry and help thousands of Canadians get back to work. Upwards of 100 leaders have spoken out about what the offshore means to them and their organization.

Over the next 10 years, the estimated loss to the province due to deferment and loss of oil and gas exploration and development projects could be substantial:

The world is moving towards a low carbon economy. Newfoundland and Labradors offshore oil and gas industry represents one of the lowest carbon per barrel footprints in the world. Greenhouse gas emissions can be further reduced by making immediate investments in the development of lower carbon fossil fuels. Reducing global emissions by providing the world with Newfoundland and Labrador oil to help supply increasing global energy demand is a valuable contribution to the fight against climate change.

Newfoundland and Labradors offshore oil and gas industry fully supports protecting the environment, reducing carbon emissions and working with governments to meet provincial, national, and international emissions reduction targets.

Through its commitment to lower carbon and clean technology, the offshore oil and gas industry will be a catalyst for clean growth innovation. The technologies developed will also accelerate the diversification of the provinces economy.

The Newfoundland and Labrador approach mirrors that of Norway, a global environmental leader, which has steadily increased oil and gas production since 2012 due to its governments policy of stimulating exploration and development while simultaneously taking significant actions to move to a low carbon economy and developing new clean technologies that are being exported worldwide. Newfoundland and Labrador can lead Canadas energy future and make Canada a global clean growth leader like Norway.

Theimportance of the oil industry to the economy of Newfoundland and Labradorcannot be overstated with an estimated 30 per cent of GDP, 13 per cent oflabour compensation and 10 per cent of employment (over the 2010 to 2017period). As of March 31, 2020 there were 6,390 people directly employed on NLoffshore oil and gas development projects while thousands more were employed insupporting industries.

All Canadians are encouraged to join in this call for support for the offshore. To ask your Member of Parliament, and members of the federal cabinet, to support the offshore oil and gas industry, please visit: http://www.energycitizens.ca/noia.

Did you enjoy this article?

Read this article:

Newfoundland and Labrador's offshore oil and gas industry represents one of the lowest carbon per barrel footprints in the world. | OUR GREAT MINDS -...

At 3.1% CAGR, Offshore Support Vessel Services Market Size is Projected to be Around US$ 16240 million by 2025 – Cole of Duty

The Offshore Support Vessel Services market study Added by Market Study Report, LLC, provides an in-depth analysis pertaining to potential drivers fueling this industry. The study also encompasses valuable insights about profitability prospects, market size, growth dynamics, and revenue estimation of the business vertical. The study further draws attention to the competitive backdrop of renowned market contenders including their product offerings and business strategies.

The global Offshore Support Vessel Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 16240 million by 2025, from USD 14390 million in 2019.

Request a sample Report of Offshore Support Vessel Services Market at:https://www.marketstudyreport.com/request-a-sample/2468666?utm_source=coleofduty.com&utm_medium=SP

The report uncovers important insights of the Offshore Support Vessel Services market and includes projections with respect to revenue, industry size, and sales volumes over the study period. Additionally, the Offshore Support Vessel Services market report provides detailed information regarding industry segmentations as well as the driving factors that will propel the profitability graph of the industry.

A glimpse of the Offshore Support Vessel Services market with respect to the geographical landscape:

Other important inclusions of the Offshore Support Vessel Services market are listed below:

Ask for Discount on Offshore Support Vessel Services Market Report at:https://www.marketstudyreport.com/check-for-discount/2468666?utm_source=coleofduty.com&utm_medium=SP

Important Features that are under Offering and Offshore Support Vessel Services Market Highlights of the Reports:

The Questions Answered by Offshore Support Vessel Services Market Report:

For More Details On this Report: https://www.marketstudyreport.com/reports/global-offshore-support-vessel-services-market-2020-by-company-regions-type-and-application-forecast-to-2025

Some of the Major Highlights of TOC covers:

Offshore Support Vessel Services Regional Market Analysis

Offshore Support Vessel Services Segment Market Analysis (by Type)

Offshore Support Vessel Services Segment Market Analysis (by Application)

Offshore Support Vessel Services Major Manufacturers Analysis

Related Reports:

1. Global Artificial Intelligence in Medicine Market 2020 by Company, Regions, Type and Application, Forecast to 2025This report categorizes the Artificial Intelligence in Medicine market data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors Analysis.Read More: https://www.marketstudyreport.com/reports/global-artificial-intelligence-in-medicine-market-2020-by-company-regions-type-and-application-forecast-to-2025

2. Global Artificial Intelligence in Manufacturing and Supply Chain Market 2020 by Company, Regions, Type and Application, Forecast to 2025Artificial Intelligence in Manufacturing and Supply Chain Market report starts from illustration of Industry Chain structure, and portrays industry condition, at that point investigations advertise size and figure of Artificial Intelligence in Manufacturing and Supply Chain by item, district and application, likewise, this report presents showcase rivalry circumstance among the merchants profile, plus, advertise value examination and esteem chain highlights are canvassed in this report.Read More: https://www.marketstudyreport.com/reports/global-artificial-intelligence-in-manufacturing-and-supply-chain-market-2020-by-company-regions-type-and-application-forecast-to-2025

Read More Reports On: https://www.marketwatch.com/press-release/rfid-printer-market-size-industry-analysis-share-growth-trends-top-key-players-and-regional-forecast-2020-2026-2020-07-10

Contact Us:Corporate Sales,Market Study Report LLCPhone: 1-302-273-0910Toll Free: 1-866-764-2150 Email: [emailprotected]

Read more:

At 3.1% CAGR, Offshore Support Vessel Services Market Size is Projected to be Around US$ 16240 million by 2025 - Cole of Duty

Offshore Installation Begins at TPC Changhua Wind Farm – Offshore WIND

Jan De Nul has begun the offshore installation activities at Taiwan Power Companys Changhua Phase 1 offshore wind project in Taiwan.

The company installed the first 12 pin piles out of 44 in the first phase of the work using Heerema Marine Contractors vessel Aegir.

Forty more pin piles will be shipped from the fabrication yard in South Korea to Taiwan in the coming weeks, Jan De Nul said.

In addition, Jan De Nuls cable-laying vessel Willem de Vlamingh started with the installation of the submarine export cables, and the first out of four cables was pulled to the onshore junction box near Fangyuan.

The landfall works were executed by two of the companys Starfishes, trenching excavators, and with the support of Hung Hua Construction.

The COVID-19 outbreak has a severe impact on our activities,said Peter De Pooter, Manager Renewables at Jan De Nul Group.However, we have been able to take the first hurdles caused by this pandemic. It is a relief that we now have been able to start the actual installation works. We are fully determined to continue our engagement in the expansion of the offshore wind energy in Taiwan.

The 109.2 MW Changhua Phase 1 project will comprise 21 5.2 MW turbines scheduled to be completed by the end of the year.

The Jan De Nul-Hitachi consortium secured the contract for the project at the beginning of 2018.

Jan De Nul is responsible for the design, fabrication and installation of the foundations, the installation of turbines, the supply and installation of the onshore and offshore cables, as well as for the upgrading of the substation.

Hitachi is in charge of manufacturing, assembly, operation and maintenance, and other works related to the turbines.

Read the original post:

Offshore Installation Begins at TPC Changhua Wind Farm - Offshore WIND

Autonomous Offshore Wind Guard Vessel Introduced – Offshore WIND

A consortium comprising C-Job Naval Architects, LISA, SeaZip Offshore Service, Sea Machines, MARIN, and eL-Tec elektrotechnologie has unveiled a concept design for an Autonomous Guard Vessel (AGV), to be used for surveillance of offshore wind infrastructure, from wind farms to substation platforms and cable routes.

The vessel, whose design was introduced on 7 July, is said to have low operating costs, since it requires no crew on board, as well as low carbon emissions, as it incorporates environmentally friendly propulsion solutions.

Given that the accommodation facilities are eliminated, the vessel is considerably smaller than the existing guard vessels, which leads to lower propulsion requirements and for the vessel to be powered by batteries. This altogether results in lower operating costs, according to the consortium behind the project.

[The] ship has solar panels across the top which allows for the continuation of navigation and communications in case the batteries run out of power, said Rolph Hijdra, Autonomous Research Lead at C-Job Naval Architects.

Contrary to current guard vessels, the AGV will continue to be operational even with rough sea conditions and have minimal underwater noise owing to the smaller size, reduced propulsion requirements and absence of a diesel engine, Rolph Hijdra said.

The vessel will recharge its batteries at a charging station, which can be moored independently, or connected to an existing equipment onsite. Charging could either be via a cable connection to the on-site equipment such as an offshore transformer platform, or locally generated using renewable fuels.

The Autonomous Guard Vessels will be constantly patrolling the area and take turns recharging. One fully charged AGV will remain on stand-by supporting operations if a situation arises, said Harm Mulder, Operations Manager at SeaZip Offshore Service.

The AGV will carry out its tasks by continuously monitoring nearby marine traffic visually, via radar, and through AIS data. With any vessel that approaches the offshore area the AGV is securing, established measures will be taken to avoid collisions and damage to the offshore infrastructure.

An intruding vessel can be communicated with and will receive information on how to safely navigate the area as well as being physically escorted away from the site by the Autonomous Guard Vessel. Additionally, the encounter will be recorded to provide video footage in case of any violation or accident, the project consortium states.

Go here to see the original:

Autonomous Offshore Wind Guard Vessel Introduced - Offshore WIND

June 2020 Global Offshore Catering Services Market Research Report is Projected to Witness Considerable Growth by 2027FOSS ESG, MAKO, Oceanwide, OSSA…

The Global Offshore Catering Services Market report provides thorough insights and also announcesvarious significant factors that are enhancing the growth of the global Offshore Catering Services market, along with available opportunities that cloud be used by the producers and current trends that is influencing the global Offshore Catering Services market. Moreover, the global Offshore Catering Services market report also covers fluctuating tendencies that directly or indirectly impact the market. These tendencies are evaluated and incorporated in the report which helps to give the complete information that is related to the market and assist in better decision making. In addition to this, the market report also highlights the Offshore Catering Services market drivers, restrains and future opportunities that influencethe growth of the global Offshore Catering Services market.To know more contact: [emailprotected] or call us on +1-312-376-8303.

The report covers profiles of top players that are functioning in the Offshore Catering Services Market: FOSS ESG, MAKO, Oceanwide, OSSA Offshore Catering, WellScope, Triangle, GREENWOOD, Compass Group, Global Offshore Logistics(GOL), Bailey, Al.Ma.Alimentari Marittimi, ROYAL INTERNATIONAL, AcadianaLLC, Tsebo, Al Kuhaimi, Zodiac Marine Services, Petit Paris Limited

Global Offshore Catering Services Market Segmentation: By Types Catering Hotel Staff, Supply of Food Food & Beveragess and Bonded Stores, Galley Equipment Design, Cleaning of Accommodation, Others

Global Offshore Catering Services Market Segmentation: By Applications Offshore Oil, Navy, Entertainment, Others

Inquiry For Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/servicesoftware/offshore-catering-services-market-report#download_report

Global Offshore Catering Services Market Segmentation: By RegionGlobal Offshore Catering Services market report categorized the information and data according to the major geographical regions which are expected to impact onthe industry in forecast period. North America (U.S., Canada, Mexico) Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) Latin America (Brazil, Rest of L.A.) Middle East and Africa (Turkey, GCC, Rest of Middle East)

Access Exclusive Free Sample Report (Impact of Coronavirus On global Offshore Catering Services Market): Click Here>Ask for the report brochure (Pandemic Impact Analysis Updated Edition May 2020)

The Offshore Catering Services market report offers a segment which covers country-wise response for the Offshore Catering Services and also offers a market outlook. Along with this, new technological developments are examine in this report as well as a competitive landscape is also involved that helps to provide audiences with a dashboard view. Moreover, the report study also considers key manufacturers for exploring comprehensive market share analysis of Offshore Catering Services market. In addition to this, the report offers detailed information of the manufacturers which includes their business and growth strategies, current development and crucial offerings in the global Offshore Catering Services market.

Global Offshore Catering Services Market Report: Research MethodologySecondary research is used in the report for analysing the market, which is authorised and confirmed by primary interviews. These primary interviews are investigatedand reconfirmed prior to including it in the report.The weighted average price and price of Offshore Catering Services is calculated across all the evaluated regions, along with this, the market worth of the global Offshore Catering Services market is also considered from that data which is assumed from the average selling price and market volume.

Request Free Sample Copy of Offshore Catering Services Market Research [emailprotected] https://www.cognitivemarketresearch.com/servicesoftware/offshore-catering-services-market-report#download_report

The future of the market is predicted based on the various macroeconomic factors and changing trends that are observed in the global Offshore Catering Services market. Other significantfactors that is covered in the report are demand of the market, supply chain, current trends in the market and other dynamic scenarios of the market. In addition to this, other important measures like year-on-year growth and dollar opportunity is also provided in the report which gives clear insights and upcomingprospects.Impact of Covid-19 in Offshore Catering Services Market

The current utility-owned Offshore Catering Services marketis affected mainly by the COVID-19 (Corona Virus Disease) pandemic. There has been delay in most ofthe projects that are in China, the US, Germany and South Korea, as well as companies in these regions are also facing temporaryoperative issues due to absence of site access and constrains in the supply chain. Due to the outburst of COVID-19 in china, Japan and India, Asia-Pacific region is predicted to get extremely affected by the spread of the COVID-19. China is the epic centrefor Corona virus disease and is a major country in terms of the chemical industry.

About Us:Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market.Contact Us: +1-312-376-8303Website: http://www.cognitivemarketresearch.comEmail: [emailprotected] or call us on +1-312-376-8303.Address: 20 N State Street, Chicago, Illinois, 60602, United States.

**********Download the Entire Report*************************************************https://www.cognitivemarketresearch.com/servicesoftware/offshore-catering-services-market-report

See the article here:

June 2020 Global Offshore Catering Services Market Research Report is Projected to Witness Considerable Growth by 2027FOSS ESG, MAKO, Oceanwide, OSSA...

Sizing up Somalia: a new offshore oil frontier in the making – Offshore Technology

]]> Siva Prasad, senior analyst at Rystad Energy

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.

Since the late 60s, civil unrest has prohibited the exploitation of Somalias offshore oil and gas resources. Now, however, after several years of relative peace, the government is making a bid to attract foreign investment to develop the countrys oil and gas riches.

In May, Somalias Ministry of Petroleum and Mineral Resources launched its first offshore licensing round, featuring up to seven blocks that can be bid for between August 2020 and March 2021.

According to seismic data processing company Spectrum, which acquired approximately 20,000 km of long-offset 2D seismic data offshore Somalia in 2015, there are strong indications of widespread distribution of good quality source rocks. Meanwhile, another subsurface data company, TGS, estimates un-risked resources for the Somali Basin could be around 30 billion barrels of oil. TGS has acquired more than 40,000 kilometres of 2D data, which covers the seven blocks on offer,

Overall, the country, located in the Horn of Africa and bordered by Kenya and Ethiopia and close to Yemen, is a promising new frontier for oil exploration; it is not without its risks and challenges though.

Oil and gas exploration started in Somalia in the 1950/60s, with a total of 70 wells drilled, 80% of which were onshore. Many major companies, including ExxonMobil, BP, Texaco, and Shell, were active in the region at the time. In the 60s, before civil unrest stifled the sector, five discoveries were made but all were considered sub-commercial.

As such, Somalia, which relies heavily on fossil fuels for its energy supply, does not produce oil. Keen to change this fact, the government ratified a new Petroleum Law in February, revoking the one passed in 2008.

The law established the Somali National Oil Company, which will participate in petroleum operations, as well as the Somali Petroleum Authority, which will act as a regulatory body overseeing oil and gas activity.

Siva Prasad, senior analyst at Rystad Energy, says that the passing of this law resolved a key barrier to exploration offshore Somalia.

It created a petroleum authority that can negotiate with international oil companies, which has been a main concern for potential investors, says Prasad.

After passing the law, Somalia reached an agreement with a Shell/Exxon joint venture (JV) for an initial roadmap to explore and develop potential offshore oil and gas reserves in march. The agreement enables the conversion of old concessions held by the JV, which were previously put into force majeure, to the new production sharing contract. The JV reportedly agreed to pay the government $1.7m for historic leasing of the blocks.

Alessandro Piccoli, technical research principal at IHS Markit, says that the ongoing negotiations between the majors and the authority should be seen as positive.

Exxon and Shell are currently negotiating with the authority for those blocks, maybe its a good sign because otherwise they will just relinquish them and leave the country, says Piccoli.

He notes there will be an onshore well drilled by Genel Energy in 2021, which he says will be interesting to follow because it is said that plays in this basin are similar to a northern Yemeni basin that has proved prolific.

As part of the Petroleum Law, which was passed with the support of the International Monetary Fund, the government has created a new revenue-sharing agreement, which details how future revenues from the development of the industry will be shared between the federal government and the six federal member states.

However, relations between the federal government and the member states are strained and Piccoli says some perceive the new petroleum law as being imposed on them.

As such, the positive participation of all the regions in the country remains doubtful, adds Prasad.

The Republic of Somaliland never took part in any of the discussions leading to the ratification of the law. The Puntland and Jubbaland states also rejected the new law and withdrew from the licensing process. All of this raises questions on the stability and the eventual validity of the Petroleum Law, says Prasad.

There are other challenges facing the development of Somalias oil reserves. Prasad says that the spending cuts announced by companies worldwide amid the Covid-19 pandemic is already taking its toll on exploration in Africa and may also affect the interest of the operators in venturing into the frontier waters of an internally troubled state.

Hence it remains to be seen whether the set deadlines will actually hold or get extended, and also if the Petroleum Law gains some stability over the months to come, he says.

Somalias plans have already been disrupted by the coronavirus outbreak. The first offshore licensing round was planned to be a physical roadshow in Houston with 15 blocks on offer. However, it had to be held virtually and the number of blocks were reduced to seven frontier blocks.

The reduced number of blocks on offer may be in reaction to the exploration spending cuts announced by E&P operators globally, says Prasad.

The country is also seeing an increasing number of Covid-19 cases.

Other ongoing issues likely to be monitored closely by operators and potential investors are the postponed election, which was scheduled to take place in March but was delayed due to the coronavirus, and the outcome of an ongoing maritime border dispute between Somalia and neighbouring Kenya. The International Court of Justice will hear the case next year, also postponed due to Covid-19. The main dispute is over three offshore oil and gas blocks currently licensed to Eni and, at present, considered part of Kenyas territory.

Somalia also represents a corruption risk; it currently ranks the lowest out of 180 countries on the Transparency Initiative Corruption Index.

For now, the industry is waiting to see what happens; will there be much interest in the licencing round come August and will activity go ahead next year as planned? These are some of the key questions.

Well see how people come and go and if they will decide to drill because, for the moment, not much is happening, its only planned activity. But Exxon and Shell staying on, thats quite positive, concludes Piccoli.

See original here:

Sizing up Somalia: a new offshore oil frontier in the making - Offshore Technology

Would offshore oil incentives help us right now? Be careful what you wish for – CBC.ca

An oil rig sits off in the distance in Bay Bulls. Based on our offshore history, incentives for oil exploration come with a price, writes guest columnist Patrick Laracy. (Submitted by Tyson Hodder)

This column is an opinionby Patrick Laracy, ageologist and lawyer in the petroleum and mineral industries.For more information aboutCBC's Opinion section, please see theFAQ.

There appears to be a growing chorus in favour of offshore oil exploration incentives in the belief it will offset some of the stress currently facing the local industry.

Given the turmoil in the oil markets and the resulting fallout, I suspect that the only effective solution to low oil prices will be higher prices. Based on our offshore history, incentives for oil exploration come with a price.

Having worked for the provincial government in the early Nineties and represented the province on various offshore joint committees with Ottawa and Nova Scotia, my experience is that Ottawa has never been fond of our power under the Atlantic Accord. Both of these realities are linked.

It is worth reminding ourselves that the Petroleum Incentives Program (PIP) of the early Eighties was a child of the National Energy Program (NEP) and the promotion of federal interests in the offshore through Petro-Canada. I worked at Petro-Canada in Calgary at the time.

The NEP, among other things, expropriated 25 per cent of all the petroleum interests offshore without adequate compensation to the interest holders. PIP grants were really an attempt to placate industry for that federal overreach, while also asserting greater federal influence in the offshore. A clever piece of manoeuvering.

This happened when Canada's self sufficiency and security of oil supply was a legitimate concern.

In fact, the Atlantic Accord contains a "security of supply" provision. When security of supply is not in jeopardy in the country, as is the current situation, the province has paramount jurisdiction on key decision-making in the offshore.

That has been the case since the Nineties, and as such the province has ultimate authority over the approval of offshore projects. This authority is coupled with the province's power in the Atlantic Accord to set the fiscal framework for any development.

In other words, the province can set terms for a particular project which can make that project economically viable or not an unprecedented power federally delegated to the province.

But, this power structure assumes that whether or not a project proceeds is primarily an economic one and not an environmental one.

With the recent changes to the federal offshore environmental review process (formerly Bill 69), the provincial power is susceptible to being undermined if projects are hijacked by environmental roadblocks, thus nullifying economics as the determinative factor in their development.

To use a familiar metaphor, Bill 69 has shifted the (environmental review) fence posts. This creates further uncertainty in the regulatory process which is not in the provincial interest nor in industry's interest.

The Atlantic Accord Review Agreement of April 2019 was being negotiated at the same time that Bill 69 was being ushered through the legislative process. The Review Agreement provides the province with a stream of cash payments funded primarily by the proceeds from the federal government's 8.5 per cent equity ownership interest in Hibernia.

Further, in that agreement the province "agreed to restrict petroleum activities in the proposed Laurentian Channel Marine Protected Area" (Sydney Basin and St. Pierre Bank region). In other words, we reduced the size of our open offshore area for exploration by 11,580 square kilometres.

In an attempt at balance, the agreement couples this concession with the acknowledgement that exploration could proceed in the Northeast Slope Marine Refuge (Orphan Basin) area.

But exploration could proceed there anyway under the Atlantic Accord, so we gained nothing in that regard which we didn't already have. It would seem, on the face of it, that incentives come with a price.

That is not to say that the price for future trade-offs may not be worth the benefits gained.

That will depend on the province's ability to fully understand the context of the negotiation and the implications thereof, all muddled in the politics of the day. As such, any demands for incentives for exploration should be made with some thoughtful consideration as to what we are prepared to give up in return.

Given the vulnerable state of our economy, we should be particularly careful.

The offshore is critical to our economic recovery. Desperation is never a good bargaining strategy and we know that the realities of the oil industry change rapidly.

Higher oil prices will be the cure for our current offshore anxieties. In the interim, we should reduce regulatory red tape and facilitate favorable tax and royalty structures to maintain competitiveness with other jurisdictions.

Besides, should we not be focused on the immediate production (i.e., Terra Nova) and development (i.e., West White Rose) challenges we face?

Read more from CBC Newfoundland and Labrador

Follow this link:

Would offshore oil incentives help us right now? Be careful what you wish for - CBC.ca